HeimRHHBF • OTCMKTS
add
Roche Holding AG
Við síðustu lokun
285,71 $
Dagbil
288,23 $ - 305,00 $
Árabil
243,42 $ - 368,43 $
Markaðsvirði
233,72 ma. USD
Meðalmagn
101,00
V/H-hlutf.
154,54
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(CHF) | jún. 2024info | Breyting á/á |
---|---|---|
Tekjur | 15,38 ma. | 0,46% |
Rekstrarkostnaður | 6,22 ma. | 0,75% |
Nettótekjur | 3,13 ma. | -12,32% |
Hagnaðarhlutfall | 20,35 | -12,70% |
Hagnaður á hvern hlut | — | — |
EBITDA | 6,17 ma. | 1,01% |
Virkt skatthlutfall | 18,56% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(CHF) | jún. 2024info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 8,81 ma. | 17,38% |
Heildareignir | 95,79 ma. | 13,53% |
Heildarskuldir | 62,91 ma. | 16,44% |
Eigið fé alls | 32,88 ma. | — |
Útistandandi hlutabréf | 796,79 m. | — |
Eiginfjárgengi | 7,87 | — |
Arðsemi eigna | 14,16% | — |
Ávöxtun eigin fjár | 19,64% | — |
Peningaflæði
Breyting á handbæru fé
(CHF) | jún. 2024info | Breyting á/á |
---|---|---|
Nettótekjur | 3,13 ma. | -12,32% |
Handbært fé frá rekstri | 3,96 ma. | 0,20% |
Reiðufé frá fjárfestingum | -1,43 ma. | -494,40% |
Reiðufé frá fjármögnun | -2,72 ma. | 34,29% |
Breyting á handbæru fé | -276,00 m. | 56,57% |
Frjálst peningaflæði | 3,19 ma. | -2,82% |
Um
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.
F. Wikipedia
Framkvæmdastjóri
Stofnsett
1. okt. 1896
Höfuðstöðvar
Vefsvæði
Starfsfólk
103.605